Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 1, 2007, Pages

  Morley, Deborah ^a   Litwak, Kenneth ^b   Ferber, Paul ^c   Spence, Paul ^d   Dowling, Robert ^b   Meyns, Bart ^e   Griffith, Bartley ^f   Burkhoff, Daniel ^c,g  

^a CircuLite Inc   (United States)

^b University of Louisville School of Medicine   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d University of Leuven ^*

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; HEART ASSIST DEVICE; HEART FAILURE; HEART OUTPUT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; PREDICTION; PRIORITY JOURNAL;

EID: 33845803269     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.07.037     Document Type: Article

References (15)

1. Mancini D., and Burkhoff D. Mechanical device-based methods of managing and treating heart failure. Circulation 112 (2005) 438-448
2. Burkhoff D., Holmes J.W., Madigan J., Barbone A., and Oz M.C. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 43 (2000) 19-26
3. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
4. Bristow M.R., Feldman A.M., and Saxon L.A. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators [In Process Citation]. J Card Fail 6 (2000) 276-285
5. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al., U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
6. Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H., Mohacsi P., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
7. Burkhoff D, Dickstein M, Ferber P. The heart simulator. Available at: http://www.columbia.edu/itc/hs/medical/heartsim/. Accessed 2005.
8. Burkhoff D., and Tyberg J.V. Why does pulmonary venous pressure rise following the onset of left ventricular dysfunction: a theoretical analysis. Am J Physiol Heart Circ Physiol 265 (1993) H1819-H1828
9. Santamore W.P., and Burkhoff D. Hemodynamic consequences of ventricular interaction as assessed by model analysis. Am J Physiol Heart Circ Physiol 260 (1991) H146-H157
10. Dickstein M.L., and Burkhoff D. A theoretical analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant 15 (1996) 715-721
11. Dickstein M.L., Spotnitz H.M., Rose E.A., and Burkhoff D. Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg 113 (1997) 1032-1040
12. Artrip J.H., Oz M., and Burkhoff D. Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J Thorac Cardiovasc Surg 122 (2001) 775-782
13. Schima H., Vollkron M., Boehm H., Rothy W., Haisjackl M., Wieselthaler G., et al. Weaning of rotary blood pump recipients after myocardial recovery: a computer study of changes in cardiac energetics. J Thorac Cardiovasc Surg 127 (2004) 1743-1750
14. Litwak K.N., McMahan A., Lott K.A., Lott L.E., and Koenig S.C. Monensin toxicosis in the domestic bovine calf: a large animal model of cardiac dysfunction. Contemp Top Lab Anim Sci 44 (2005) 45-49
15. Suga H. Ventricular energetics. Physiol Rev 70 (1990) 247-277